NPPA grants price exemption for Torrent Pharma's FDC drug

Torrent Pharma has apparently become the first company to receive price exemption for a new drug from National Pharmaceutical Pricing Authority (NPPA) under the new drug pricing policy, which came into effect last year, according to a Business Standard. The Ahmedabad-based drug maker has secured an exemption from price control for one of its newly developed fixed dose combination (FDC) products.
 
The company’s FDC containing prasugrel hydrochloride 10 mg plus aspirin 75 mg has been granted an exemption by NPPA for five years. This means Torrent Pharma is free to price the medicine for five years, after which it will have to seek NPPA approval. However, the regulator has also asked the company to keep it informed about the maximum retail price.
 
FOR COMPLETE REPORT READ: Torrent Pharma gets price exemption for new drug